Ling Xiao

493 total citations
37 papers, 254 citations indexed

About

Ling Xiao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Ling Xiao has authored 37 papers receiving a total of 254 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 7 papers in Pulmonary and Respiratory Medicine and 6 papers in Oncology. Recurrent topics in Ling Xiao's work include Radiomics and Machine Learning in Medical Imaging (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ling Xiao is often cited by papers focused on Radiomics and Machine Learning in Medical Imaging (6 papers), Prostate Cancer Diagnosis and Treatment (5 papers) and Prostate Cancer Treatment and Research (5 papers). Ling Xiao collaborates with scholars based in China, United States and Switzerland. Ling Xiao's co-authors include Hong Zhang, Ying Ye, Mengyao Sun, Khalid Rahman, Mengyao Sun, Qianhong Li, Huirong Zhang, Shuo Hu, Yongxiang Tang and Wenrui Ma and has published in prestigious journals such as Nature Medicine, Analytical Chemistry and Scientific Reports.

In The Last Decade

Ling Xiao

32 papers receiving 248 citations

Peers

Ling Xiao
Ling Xiao
Citations per year, relative to Ling Xiao Ling Xiao (= 1×) peers JI Zhao-ning

Countries citing papers authored by Ling Xiao

Since Specialization
Citations

This map shows the geographic impact of Ling Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Xiao more than expected).

Fields of papers citing papers by Ling Xiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Xiao. The network helps show where Ling Xiao may publish in the future.

Co-authorship network of co-authors of Ling Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Xiao. A scholar is included among the top collaborators of Ling Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Xiao. Ling Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xiao, Ling, et al.. (2026). In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trial. Nature Medicine. 32(3). 1045–1051.
2.
Shi, Yan‐Ni, et al.. (2025). USP10 stabilizes BAZ1A to drive tumor stemness via an epigenetic mechanism in head and neck squamous cell carcinoma. Cell Death and Disease. 16(1). 270–270. 1 indexed citations
3.
Wang, Weikang, Ling Xiao, Ruimei Feng, et al.. (2025). Prevalence of thyroid nodules and canceration risk assessment in TIRADS, and their relationships to obesity and dysglycemia. Frontiers in Oncology. 15. 1658717–1658717.
4.
Molitoris, Jason K., Ling Xiao, Lisa M. Schumaker, et al.. (2025). Graph feature selection for enhancing radiomic stability and reproducibility across multiple institutions in head and neck cancer. Scientific Reports. 15(1). 27995–27995.
5.
Li, Yujia, Ling Xiao, Ming Zhou, et al.. (2025). Which patients with negative PSMA-PET imaging can safely avoid biopsy for prostate cancer? a novel step towards PSMA-based biopsy-free strategy. European Journal of Nuclear Medicine and Molecular Imaging. 52(6). 2051–2062. 2 indexed citations
6.
Xiao, Ling, Gregory S. Alexander, Jason K. Molitoris, et al.. (2024). Radiomic biomarkers of locoregional recurrence: prognostic insights from oral cavity squamous cell carcinoma preoperative CT scans. Frontiers in Oncology. 14. 1380599–1380599. 6 indexed citations
9.
Xiao, Ling, Ming Zhou, Yujia Li, et al.. (2024). [68Ga]Ga‑PSMA‑617 PET-based radiomics model to identify candidates for active surveillance amongst patients with GGG 1–2 prostate cancer at biopsy. Cancer Imaging. 24(1). 86–86. 2 indexed citations
10.
Liu, Junchen, Wenrui Ma, Hongyan Zhang, et al.. (2023). Anti-Inflammatory Activity of Panax notoginseng Flower Saponins Quantified Using LC/MS/MS. Molecules. 28(5). 2416–2416. 13 indexed citations
11.
Xiao, Ling, Gregory S. Alexander, Jason K. Molitoris, et al.. (2023). Identification of CT-based non-invasive radiomic biomarkers for overall survival prediction in oral cavity squamous cell carcinoma. Scientific Reports. 13(1). 21774–21774. 13 indexed citations
12.
Xiao, Ling, et al.. (2023). Low-dose methotrexate-induced renal failure in a patient with ectopic pregnancy: a case report. Journal of Medical Case Reports. 17(1). 119–119. 4 indexed citations
13.
Huang, Xiao‐Ying, Mingyang Ma, Ling Xiao, et al.. (2023). Associations between body composition profile and hypertension in different fatty liver phenotypes. Frontiers in Endocrinology. 14. 1247110–1247110. 2 indexed citations
14.
Zhong, Wenhui, Huizhen Wang, Xiang Luo, et al.. (2023). Fibroblast growth factor 21 alleviates unilateral ureteral obstruction-induced renal fibrosis by inhibiting Wnt/β-catenin signaling pathway. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1871(2). 119620–119620. 5 indexed citations
15.
Zhang, Huirong, Wenrui Ma, Miaomiao Guo, et al.. (2023). Microencapsulation protects the biological activity of sea buckthorn seed oil. Frontiers in Nutrition. 9. 1043879–1043879. 15 indexed citations
16.
Li, Jian, Ling Xiao, Ming Zhou, et al.. (2023). 68Ga-PSMA PET/CT-based multivariate model for highly accurate and noninvasive diagnosis of clinically significant prostate cancer in the PSA gray zone. Cancer Imaging. 23(1). 81–81. 8 indexed citations
17.
He, Guoqian, Ling Xiao, Zhen Pan, et al.. (2022). Case report: A rare case of pulmonary mucormycosis caused by Lichtheimia ramosa in pediatric acute lymphoblastic leukemia and review of Lichtheimia infections in leukemia. Frontiers in Oncology. 12. 949910–949910. 9 indexed citations
18.
Liu, Zhuanzhuan, Yudi Li, Shihong Xu, et al.. (2022). Transcriptome analysis of Aedes albopictus midguts infected by dengue virus identifies a gene network module highly associated with temperature. Parasites & Vectors. 15(1). 173–173. 5 indexed citations
19.
Orr, Laurel, Simran Arora, Sen Wu, et al.. (2020). Bootleg: Chasing the Tail with Self-Supervised Named Entity Disambiguation. Conference on Innovative Data Systems Research. 2 indexed citations
20.
Sun, Mengyao, et al.. (2016). DAIDZEIN: A REVIEW OF PHARMACOLOGICAL EFFECTS. African Journal of Traditional Complementary and Alternative Medicines. 13(3). 117–132. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026